Emcure Pharmaceuticals Ltd

Healthcare

10 July, 2024

Bain-backed Emcure Pharma jumps 35% on listing at $223 mn valuation

Indian drugmaker Emcure Pharmaceuticals' shares rose 34.9% in debut trade on Wednesday, beating analysts' estimates and valuing the company at ......

Healthcare

05 July, 2024

Bain-backed Emcure Pharma attracts bids worth $11 bn in IPO

India's Emcure Pharmaceuticals drew strong interest for its $234 million initial public offering (IPO) as investors bet on its slate ......

Pro

Healthcare

02 July, 2024

Bain Capital stares at modest returns from another legacy India bet

Bain Capital, a bulge-bracket global private equity firm which has been on a harvest spree in India and signed off from two ......

Premium

Healthcare

20 December, 2023

Bain Capital tweaks exit plan from decade-old India portfolio company

American private equity firm Bain Capital, which has been particularly active in India this year having struck three new deals ......

Healthcare

25 September, 2023

Bain Capital-backed Emcure Pharma plans IPO, hires bankers

India's Emcure Pharmaceuticals aims to raise $400-$500 million from an initial public offering planned for next year, two sources said, ......

Premium

Healthcare

07 February, 2019

Company watch: Is Bain-backed Emcure on road to recovery after two years of pain?

In July 2015, the US health regulator banned imports from a Pune factory of Emcure Pharmaceuticals Ltd. The ban crimped ......

Healthcare

03 October, 2017

Eris Lifesciences acquires nutraceuticals maker UTH Healthcare

Drugmaker Eris Lifesciences Ltd has acquired nutraceuticals maker UTH Healthcare Ltd for Rs 12.85 crore ($1.96 million) in cash.Eris said ......

Premium

Healthcare

10 July, 2017

Company watch: Regulatory risks may weigh on Bain Capital-backed Emcure Pharma

India’s generics pharmaceutical industry has been hit over the past few years ever since the US Food and Drug Administration ......